Covered recipient · General Payments record
BASSAM HANI NASR
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2019
$863.16
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.80 | 19 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Allergan Inc. | $148.41 | 8 |
| ABBVIE INC. | $85.44 | 7 |
| Janssen Biotech, Inc. | $35.47 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $11.42 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648266999 | CMS |
| AbbVie, Inc. | $11.60 | 01/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648266997 | CMS |
| AbbVie, Inc. | $12.91 | 03/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648267001 | CMS |
| AbbVie, Inc. | $11.06 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648267005 | CMS |
| AbbVie, Inc. | $13.05 | 04/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648267003 | CMS |
| AbbVie, Inc. | $12.72 | 05/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648267009 | CMS |
| AbbVie, Inc. | $12.68 | 06/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648267007 | CMS |
| Allergan Inc. | $20.00 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865799 | CMS |
| Allergan Inc. | $18.00 | 01/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865803 | CMS |
| Allergan Inc. | $17.44 | 02/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865806 | CMS |
| Allergan Inc. | $19.36 | 03/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865809 | CMS |
| Allergan Inc. | $17.34 | 04/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865813 | CMS |
| Allergan Inc. | $18.55 | 05/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865815 | CMS |
| Allergan Inc. | $19.59 | 05/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865819 | CMS |
| Allergan Inc. | $18.13 | 07/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670865827 | CMS |
| Janssen Biotech, Inc. | $11.18 | 01/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658613795 | CMS |
| Janssen Biotech, Inc. | $11.05 | 02/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658613801 | CMS |
| Janssen Biotech, Inc. | $13.24 | 05/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658613805 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.48 | 06/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 684854199 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.